Opinion
Video
Author(s):
A panel of experts on myelodysplastic syndromes (MDS) introduce themselves and provide an overview of diagnosis practices, highlighting common symptoms and the typical patient presentation.
Precision Medicine Unfolds in Oncology, Bearing Substantial Implications for the Future
Camidge and Cooper on Finding Purpose and Embracing Nuance in Hospital Chaplaincy
FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Ph+ Chronic-Phase Chronic Myeloid Leukemia
Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
BGB-16673 Shows Early Activity, Tolerability in Heavily Pretreated Waldenström Macroglobulinemia
FDA Expands Approval of Methotrexate to Include Pediatric Acute Lymphoblastic Leukemia
IDE397 Shows Early Antitumor Activity, Safety in MTAP-Deletion Urothelial Cancer and NSCLC
RVU120 Shows Early Promise in R/R Metastatic or Advanced Solid Tumors
The WEE1 Inhibitor APR-1051 Shows Early Safety and Tolerability in Advanced, Mutated Solid Tumors
TYRA-300 Is Safe, Generates Preliminary Antitumor Activity in FGFR3+ Metastatic Urothelial Cancer